Clopidogrel and salt submicron emulsion injection thereof as well as preparation method of same
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHENYANG PHARMA UNIVERSITY
- Publication Date
- 2012-10-03
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, and relates to a submicroemulsion injection of clopidogrel and its salt and a preparation method thereof. Background technique
[0002] Clopidogrel, the second thienopyridine drug, is an adenosine diphosphate (ADP) receptor inhibitor. Its chemical name is (S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)acetic acid methyl ester. The chemical structural formula is as follows:
[0003]
[0004] Clopidogrel is a platelet aggregation inhibitor, which can selectively and irreversibly inhibit the binding of adenosine diphosphate (ADP) to its platelet receptor and the secondary ADP-mediated activation of the glycoprotein GPⅡb / Ⅲa complex, thereby inhibiting Mutual aggregation of platelets. In addition, clopidogrel can also block the platelet activation expansion caused by ADP release, thereby inhibiting platelet aggregation induced by other agonists.
[0005] Clopidogrel can be used t...